Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.55 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.54 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.50 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | BTK | Q06187 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7689907 | 0.98 | CYP1A2 (0.96) | CYP1A2LMNAKMT2AMEN1GPR119 | |
| SCHEMBL3452908 | 0.89 | LMNA (0.80) | CYP1A2LMNAKMT2AMEN1GPR119 | |
| SCHEMBL8898883 | 0.85 | CYP1A2 (0.73) | CYP1A2LMNAKMT2AMEN1GPR119 | |
| SCHEMBL10353459 | 0.85 | CYP1A2 (0.74) | CYP1A2LMNAKMT2AMEN1GPR119 | |
| SCHEMBL11146636 | 0.84 | CYP1A2 (0.71) | CYP1A2LMNAKMT2AMEN1GPR119 | |
| SCHEMBL1456606 | 0.81 | CYP1A2 (0.67) | CYP1A2LMNAKMT2AMEN1GPR119 | |
| SCHEMBL9687063 | 0.81 | LMNA (0.69) | CYP1A2LMNAKMT2AMEN1GPR119 | |
| SCHEMBL1751891 | 0.81 | CYP1A2 (0.68) | CYP1A2LMNAKMT2AMEN1PDE3B | |
| SCHEMBL11156334 | 0.80 | CYP1A2 (0.67) | CYP1A2LMNAKMT2AMEN1PDE3B | |
| SCHEMBL10354174 | 0.80 | CYP1A2 (0.67) | CYP1A2LMNAKMT2AMEN1GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110984423-B | Construction method of reinforced concrete wall | 广东高翔建设有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-110984423-A | Construction method of reinforced concrete wall | 广东高翔建设有限公司 | 2020-04-10 | — | — | CN | claimed |
| CN-110606716-A | Construction method of indoor partition wall | 广东优鼎装饰设计工程有限公司 | 2019-12-24 | — | — | CN | claimed |
| CN-106831600-B | The preparation method of 3- phenyl -4-6- dichloro-pyridazine | 常州沃腾化工科技有限公司 | 2019-04-12 | — | — | CN | claimed |
| CN-106831600-A | The preparation method of the dichloro-pyridazine of 3 phenyl 46 | 常州沃腾化工科技有限公司 | 2017-06-13 | — | — | CN | claimed |
| US-8747643-B2 | Plating bath and method | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2014-06-10 | — | — | US | claimed |
| US-20140027298-A1 | PLATING BATH AND METHOD | ROHM & HAAS ELECT MAT (US) | 2014-01-30 | — | — | US | claimed |
| US-20130048505-A1 | PLATING BATH AND METHOD | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-02-28 | — | — | US | claimed |
| US-4397854-A | INCREASE IN MYOCARDIAL CONTRACTILITY | WARNER-LAMBERT COMPANY (US) | 1983-08-09 | — | — | US | claimed |
| JP-55036434-A | — | — | None | — | — | JP | disclosed |
| JP-55118470-A | — | — | None | — | — | JP | disclosed |
| JP-55139364-A | — | — | None | — | — | JP | disclosed |
| JP-55139363-A | — | — | None | — | — | JP | disclosed |
| WO-2025215121-A1 | HEDGEHOG ACYLTRANSFERASE INHIBITORS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-10-16 | — | — | WO | disclosed |
| JP-S55139364-A | PYRIDAZONE DERIVATIVE, AND AGRICULTURAL AND HORTICULTURAL GERMICIDE CONTAINING SAID DERIVATIVE AS EFFECTIVE COMPONENT | SANKYO CO LTD | 1980-10-31 | — | — | JP | disclosed |
| JP-S55118470-A | THIOUREA DERIVATIVE | MORISHITA SEIYAKU KK | 1980-09-11 | — | — | JP | disclosed |
| JP-S5536434-A | 4-PHENYL-4-OXO-2-BUTENOIC ACID DERIVATIVE AND ITS PREPARATION | SANKYO CO LTD | 1980-03-14 | — | — | JP | disclosed |
| EP-0002719-A2 | Process for the preparation of 3-pyridazinones | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-07-11 | — | — | EP | disclosed |
| US-4152517-A | CYCLIZATION WITH HYDRAZINE | SMITHKLINE CORPORATION (US) | 1979-05-01 | — | — | US | disclosed |
| US-4008086-A | PYRIDONE OR PYRIDAZONE DERIVATIVES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048505-A1 | PLATING BATH AND METHOD | EPHX1, CYP7B1, AOC3 | CYP1A2 48/4885LMNA 1720/4885KMT2A 1456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.